▶ 調査レポート

ヒオスシンの世界市場:成長・動向・市場規模予測(2020-2025)

• 英文タイトル:Hyoscine Market - Growth, Trends, and Forecast (2020 - 2025)

Mordor Intelligenceが調査・発行した産業分析レポートです。ヒオスシンの世界市場:成長・動向・市場規模予測(2020-2025) / Hyoscine Market - Growth, Trends, and Forecast (2020 - 2025) / D0-MOR-AP0675資料のイメージです。• レポートコード:D0-MOR-AP0675
• 出版社/出版日:Mordor Intelligence / 2020年4月20日
• レポート形態:英文、PDF、117ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:健康管理
• 販売価格(消費税別)
  Single User¥629,000 (USD4,250)▷ お問い合わせ
  Team User¥703,000 (USD4,750)▷ お問い合わせ
  Corporate License¥1,110,000 (USD7,500)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、ヒオスシンの世界市場について調査・分析した資料で、ヒオスシンの市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。

The Hyoscine Market is expected to register a CAGR of 4% during the forecast period attributing to effective medicine for motion sickness leading to a rise in consumer awareness towards hyoscine. Moreover, Motion sickness such as nausea, vomiting may cause by an increase in travelling which further led to the adoption of hyoscine medicines. For instance, According to National Library of Medicine (NIH) in 2018, Motion sickness is the common condition characterized by travelling or motion and frequency is one in three people are susceptible to this condition which leads to the rising demand of hyoscine. Furthermore, growth in a number of surgeries supplement is also one of the factors boosting the hyoscine market attributing to use in surgeries for controlling and decreasing saliva content and gastric acid, to slow gut motility and prevent vomiting. Moreover, the rise in usage of transdermal hyoscine patches in surgeries & post-operative recovery and a rise in emphasis on community healthcare in developing countries is expected to provide a lucrative opportunity in developing countries. However, stringent regulation related to the manufacturing and marketing of hyoscine products may hamper the market to a certain extent.
Key Market Trends

Oral Hyoscine is Expected to Hold a Major Market Share in the Hyoscine Market

Oral hyoscine is expected to contribute the largest segment attributing to ease of administration, easy availability and wide preference in abdominal muscle cramp and treating motion sickness. Oral tablets compared to patches and injection will not need prescriptions and can easily available in pharmacies, leading to low health care costs and further drive the oral segment. Moreover increased patient pool and increase in travelling population is leading to a high demand of hyoscine and propel the growth of oral hyoscine market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global Hyoscine market owing to many market players operating in manufacturing the medicines, growth in number of surgeries supplements, growing healthcare concern, increasing healthcare expenditure and presence of well-established healthcare infrastructure.

Competitive Landscape

The market studied is moderately competitive and there are several international and local companies operating in this market. Some of the companies which are in the market are Caleb Pharmaceuticals, Inc, Baxter International, Alkaloids Corporation., Alchem International Pvt. Ltd, Guangzhou HanFang Pharmaceutical, MYUNGMOON PHARM CO., LTD., and Perrigo.

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format
– 3 months of analyst support

レポート目次

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Consumer Awareness Towards Hyoscine
4.2.2 Increase in Travelling
4.3 Market Restraints
4.3.1 Regulatory Framework
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Hyoscine Butylbromide
5.1.2 Hyoscine Hydrobromide
5.2 By Mode of Administration
5.2.1 Oral
5.2.2 Patches
5.2.3 Injections
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Caleb Pharmaceuticals, Inc
6.1.2 Baxter International
6.1.3 Alkaloids Corporation.
6.1.4 Alchem International Pvt. Ltd
6.1.5 Guangzhou HanFang Pharmaceutical
6.1.6 MYUNGMOON PHARM CO.,LTD.
6.1.7 Perrigo

7 MARKET OPPORTUNITIES AND FUTURE TRENDS